WAYNE, N.J., Dec. 16 MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, today announced that it has signed a three-year single source provider contract with Novation, the industry's leading supply contracting company, for MAQUET's market-leading VASOVIEW Endoscopic Vessel Harvesting (EVH) Systems. The VASOVIEW products assist healthcare providers in obtaining veins for repair of blocked coronary arteries using only small incisions. This allows for faster healing, less postoperative pain and scarring and potentially reduced risk of complications, such as infection, compared with open vein retrieval methods.
"Receiving Novation's single source provider contract for our EVH products affirms MAQUET's role as the industry leader in EVH technology," said Raoul Quintero, President of MAQUET Cardiovascular U.S. Sales LLC. "Our team is looking forward to developing partnerships with the members Novation serves. This agreement will provide the critical EVH products and support that benefit the cardiac surgery teams who will use them, as well as their patients who are undergoing a more minimally invasive surgical procedure."
The agreement was effective on November 1, 2009, and runs through September 2012. Under the terms of the agreement, MAQUET Cardiovascular will be the exclusive provider of EVH devices and supplies to the members of VHA Inc., University HealthSystem Consortium (UHC) and Provista.
"Following a rigorous review by our technology assessment and contracting teams, MAQUET met all of our process requirements for the single source contract," said Scott Crandall, Senior Director, Contract Services Cardiology at Novation. "This contract supports our continued service to members to access the highest quality technology that will best meet their needs. We are pleased to add this to the agreements we hold with MAQUET Cardiovascular."
About Endoscopic Vein Harvesting
In endoscopic vessel harvesting (EVH), a healthy blood vessel, such as the saphenous vein from the leg or the radial artery from the arm, is removed through a small incision for use during coronary artery bypass graft (CABG) surgery to bypass a blockage in the heart. Today, EVH is considered the standard of care and has been shown to reduce postoperative pain, recovery time, infection rates and scarring, and allow patients to walk sooner and recover more quickly than conventional open vein harvesting surgery. Since the first system for EVH was launched in 1997, more than 1 million procedures using VASOVIEW products have been performed.
Founded in 1998, Novation is the leading health care supply contracting company for more than 25,000 members of VHA Inc. and the University HealthSystem Consortium (UHC), two national health care alliances and nearly 15,000 members of Provista, LLC. Novation offers its customers contract development and management, supply chain data and measurement, and industry knowledge and advocacy. Based in Irving, Texas, Novation develops and manages competitive contracts with more than 500 suppliers. VHA, UHC and Provista members used Novation contracts to purchased nearly $35.7 billion in 2008.
About MAQUET Cardiovascular
MAQUET Cardiovascular is a leader in providing innovative products for cardiac surgery, vascular intervention and cardiac support to hospitals and clinics and the cardiac surgeons, interventional cardiologists, perfusionists and other healthcare professionals who care for patients with cardiovascular disease. MAQUET Cardiovascular is focused on providing clinicians with future-oriented technology that fits into their daily practice and that improves the therapeutic management of patients. MAQUET Cardiovascular continues to invest in the development of innovative technologies and solutions that advance clinical practice, improve patient outcomes and enhance quality of life.
MAQUET Cardiovascular was formed in 2003 when MAQUET combined its existing Cardiopulmonary business with Jostra's equipment and consumables for open heart surgery and Siemens Life Support Systems that GETINGE acquired in 2003. In 2008, it added the Cardiac Surgery and Vascular Interventions businesses that GETINGE acquired from Boston Scientific and Guidant in 2008. In 2009, it added the cardiac assist businesses that GETINGE acquired from Datascope. MAQUET Cardiovascular provides healthcare professionals with products in four business units: Cardiopulmonary (perfusion products), Cardiac Surgery (clampless beating heart and endoscopic vessel harvesting), Vascular Interventions (grafts for vascular surgery), and Cardiac Assist (intra-aortic balloon counterpulsation therapy).
The MAQUET Group is the global market leader for Medical Systems, focusing on the Operating Room (OR) and Intensive Care Unit (ICU). The integrated products of MAQUET are specially designed to deliver optimal clinical treatment and therapy concepts within acute care hospitals. MAQUET provides innovative medical solutions from three divisions:
MAQUET is a subsidiary of the publicly-listed Swedish GETINGE GROUP, a company with over $2.8 billion in revenues (2008 fiscal year) and 12,800 employees worldwide. In 2008 MAQUET itself generated pro-forma revenues (including the acquisition of Datascope Corp.) of over $1.4 billion. The company now has 5,000 employees in 35 international sales and service organizations, as well as a network of more than 200 sales representatives.
MAQUET - The Gold Standard.
-- Cardiovascular with products for cardiac assist (intra-aortic balloon counterpulsation therapy), coronary artery bypass surgery, aneurysm and vascular repair, peripheral interventions and extracorporeal circulation. -- Critical Care for intensive care ventilators and anesthesia machines -- Surgical Workplaces for OR tables, lights and ceiling service units, prefabricated OR and ICU suites, as well as telemedicine for the OR integration.
SOURCE MAQUET Cardiovascular LLC